Social Impact

Application of novel approaches, standards and practices which result in efficient processing, resourceful utilities and business advantage by:

  • Increasing patient access & preventing drug shortages through in-country-for country manufacturing; outbreak, epidemic, or emerging health crisis response via rapid deployment & fast-track drug production; and designs which overcome specific geographical challenges.
  • Implementing cost-effective strategies to reduce cost of drug products for consumers through implementation of new tools or techniques in manufacturing environments.
  • Accelerating a shift to sustainable facility design, intended to ensure the effective use of energy, minimize waste, reduce carbon footprint, incorporate green manufacturing techniques, reduce environmental impact.
Janssen Pharmaceuticals
iSpeak Blog
Meet the 2022 FOYA Social Impact Category Winner: Janssen Biologics

Winners in this category exemplify application of novel approaches, standards, and practices which result in efficient processing, resourceful utilities, and business advantage by increasing patient access and preventing drug shortages through in-country-for country manufacturing; outbreak, epidemic, or emerging health crisis response via rapid deployment and fast-track drug production; and...

2021 Category Winner for Social Impact

2021 Category Winner for Social Impact

FOYA
Each year, the ISPE FOYA competition recognizes a facility for its social impact. As the world continues to take on the challenges associated with a once-in-a-century pandemic, it is more than appropriate that we recognize the Government Pharmaceutical Organization (GPO) in Thailand for its social impact, as the facility manufactures vaccines and expands affordable access to life-saving medication.
2020 Category Winner for Social Impact

2020 FOYA Category Winners for Social Impact

FOYA
Learn about the two companies winning the Social Impact category for the 2020 Facility of the Year Awards: GlaxoSmithKline United Therapeutics GlaxoSmithKline Location: Parma, Italy Project: Attachment Inhibitor (AI)...